NeuroBo Pharmaceuticals CEO Ben Price receives $920K in 2021
NeuroBo Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: May 18, 2022
NeuroBo Pharmaceuticals reported fiscal year 2021 executive compensation information on May 18, 2022.
In 2021, four executives at NeuroBo Pharmaceuticals received on average a compensation package of $692K, a 86% increase compared to previous year.
Average pay of disclosed executives at NeuroBo Pharmaceuticals
Ben Gil Price, Chief Executive Officer, received $920K in total. 93% of Price's compensation, or $854K, was in option awards. Price also received $66K in salary.
Gil Price, Chief Executive Officer, received a compensation package of $920K. 93% of the compensation package, or $854K, was in option awards.
Richard Kang, Chief Executive Officer, earned $551K in 2021, a 29% increase compared to previous year.
Akash Bakshi, Chief Operating Officer, received $375K in 2021.
Related executives
You may also like
Source: SEC filing on May 18, 2022.